TECHNICAL PROPOSAL FOR THE APPLICATION OF BOTULINUM TOXIN TYPE A IN THE FRONTAL MUSCLE BASED ON THE CONTROLLED INTERSECTION OF DIFFUSION HALOS: THEORETICAL-OPERATIONAL RATIONALE

Authors

  • Thiago Borges Mattos UNINCOR
  • Lídia Batista Conrado Martins UFJF
  • João Marcos Mattos UNINCOR
  • Érica Leonel Sobral de Souza UNINCOR
  • Paula Karoline UFJF
  • Karina Cazzeta Sales Neves UFJF
  • Luiz Meireles Mayrink UNIPAC
  • Caio Salles UNINCOR

DOI:

https://doi.org/10.66104/7fsv4r76

Keywords:

Botulinum toxin type A; Technical procedure; Integrative dentistry; Intramuscular distribution; Clinical safety.

Abstract

Botulinum toxin type A (TBXA) is widely used in dental practice for aesthetic and therapeutic purposes, following traditional protocols based on equidistant injection points to avoid overlapping diffusion halos. However, the limited duration of effect and variability in clinical response indicate the need for critical evaluation of current approaches. This manuscript proposes a theoretical-operational application technique based on the controlled intersection of diffusion halos by reducing the spacing between injection points. Hypothetically, this approach could promote more homogeneous intramuscular distribution, enhance recruitment of deep muscle fibers, and improve uniformity of muscle relaxation, without increasing total administered dose. The proposal is presented as a technical hypothesis, including injection mapping, dose per point, depth of application, anatomical precautions, and provisional patient selection criteria. Discussions of functional anatomy, safety considerations, limitations, and potential experimental validation are included.

Downloads

Download data is not yet available.

References

Turton K, Chaddock JA, Acharya KR. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci. 2002;27(11):552-8 DOI: https://doi.org/10.1016/S0968-0004(02)02177-1

Wenzel RG. Pharmacology of botulinum neurotoxin serotype A. Am J Health Syst Pharm. 2004;61(22 Suppl 6):S5-10 DOI: https://doi.org/10.1093/ajhp/61.suppl_6.S5

Mostafa D. A successful management of sever gummy smile using gengivectomy and botulinum toxin injection: A case report. Internation Journal of Surgery Case Reports. 2018 DOI: https://doi.org/10.1016/j.ijscr.2017.11.055

Gimenez, R. P. (2006). Análise retrospectiva das alterações de dinâmica facial após aplicações seriadas de toxina botulínica tipo A. 131f. Dissertação (Mestrado em Ciências) - Faculdade de Medicina, Universidade de São Paulo, São Paulo.

Nattkemper, L. A.,Vander Does, A.,Stull, C. M.,et al. (2023). Prolonged Antipruritic Effect of Botulinum Toxin Type A on Cowhage-induced Itch: A Randomized, Single-blind, Placebo-controlled Trial. Acta Dermato Venereologica , 103(5),658. DOI: https://doi.org/10.2340/actadv.v103.6581

Rossetto, O., Pirazzini, M.,& Montecucco, C. (2014). Botulinum neurotoxins: genetic, structural and mechanistic insights. Nature Reviews Microbiology. 12(8),535-549. DOI: https://doi.org/10.1038/nrmicro3295

Stefane, T.,Napoleão, A. A.,Sousa, F. A. E. F.,& Hortense, P. (2012). Influência de tratamentos para enxaqueca na qualidade de vida: revisão integrativa de literatura.Revista Brasileira de Enfermagem. 65(2),353-360. DOI: https://doi.org/10.1590/S0034-71672012000200023

Published

2026-06-01

How to Cite

TECHNICAL PROPOSAL FOR THE APPLICATION OF BOTULINUM TOXIN TYPE A IN THE FRONTAL MUSCLE BASED ON THE CONTROLLED INTERSECTION OF DIFFUSION HALOS: THEORETICAL-OPERATIONAL RATIONALE. (2026). REMUNOM, 13(11), 1-12. https://doi.org/10.66104/7fsv4r76